Skip to main content

Month: August 2020

Hofseth Biocare ASA: SECOND QUARTER & HALF YEAR 2020 FINANCIAL REPORT

Hofseth BioCare reported operating revenues of NOK 20.0 million in the second quarter of 2020, an increase of 57 percent compared to the similar period last year. Operating profit (EBITDA) in the second quarter was negative NOK 17.3 million (8.3 million), as the company continues to invest in R&D and improved production processes.“Extracting high value nutrition and medical products from low value waste from salmon production is the core of our business, and I am very happy to see that have made significant progress during the second quarter, even in a market environment affected by the Covid-19 pandemic. Our revenue growth is particularly driven by the successful commercialization of our high-quality salmon oil and protein powder. Both these products have proven health benefits which make them attractive in the market. Our newly...

Continue reading

PRESS RELEASE: Nacon and Cyanide studio are pleased to announce Blood Bowl 3

THIS IS… BLOOD BOWL!The most brutal sporting event returns for a third knock out edition in 2021 Lesquin, 28 August 2020 – Strap on your boots, don your helmet, adjust your shoulder guards and chest plate… and slip a sharpened dagger into your belt (it’s the rules): NACON and Cyanide studio are pleased to announce Blood Bowl 3, the new video game adaptation of the cult Games Workshop board game. Planned for release in early 2021, the game will be available on PlayStation®4, PlayStation®5, Xbox One, Xbox Series X, Steam and Nintendo SwitchTM.Blood Bowl 3 is the videogame of fantasy football. A turn-based strategy game inspired by American football in the Warhammer fantasy world where elves, humans, orcs and other creatures fight for the ball with shoulder charges, kicks, punches and weapons of varying degrees of lethality (and legality...

Continue reading

COMMUNIQUE DE PRESSE: Nacon et le studio Cyanide sont heureux d’annoncer Blood Bowl 3

THIS IS… BLOOD BOWL !La plus brutale des compétitions sportives revient en 2021 pour un troisième volet déjantéLesquin, le 28 août 2020 – Mettez vos crampons, enfilez votre casque, ajustez vos épaulettes et votre plastron… Et glissez une dague acérée à votre ceinture (c’est réglementaire) : NACON et le studio Cyanide sont heureux d’annoncer Blood Bowl 3, la nouvelle adaptation en jeu vidéo du jeu de plateau culte de Games Workshop. Prévu pour début 2021, le jeu sera disponible sur PlayStation®4, PlayStation®5, Xbox One, Xbox Series X, Steam et Nintendo SwitchTM.Blood Bowl 3 est un jeu de stratégie au tour-par-tour inspiré du football américain dans le monde fantasy de Warhammer où elfes, humains, orques et autres créatures se disputent le ballon à coups d’épaule, de poing, de pied, et d’armes plus ou moins létales et légales. Dans la peau...

Continue reading

Vistin Pharma ASA: Second quarter and first half 2020 financial results

Oslo, Norway, 28 August 2020Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter and first half of 2020, with a 20% increase in revenue and EBITDA of MNOK 20.9 for the pharmaceutical business in Q2 – highest revenue and EBITDA ever in a quarter. For first half 2020 revenue increased by 30% and EBITDA by 200% versus first half 2019.The revenues for the second quarter of 2020 ended at MNOK 73 (Q2’19: MNOK 61.1). For first half of 2020 the revenue was MNOK 134.4, compared to MNOK 103.3 in first half of 2019, a growth of 30%.Second quarter EBITDA for pharmaceuticals was MNOK 20.9 (Q1’19: MNOK13.3), and a first half 2020 EBITDA of MNOK 35.1, compared to MNOK 11.7 in first half of 2019.The net profit for the group ended at MNOK 20.7 (Q2’19: MNOK 0.4) for the second quarter of 2020. For...

Continue reading

SAExploration Enters into Restructuring Support Agreement for Comprehensive Balance Sheet Improvement

HOUSTON, Aug. 28, 2020 (GLOBE NEWSWIRE) — SAExploration Holdings, Inc. (“SAE” or the “Company”) (OTC Pink: SAEX) announced today that it and certain of its subsidiaries have entered into a Restructuring Support Agreement (the “RSA”) with holders of 100% of the advances under its credit facility, holders of approximately 82.4% of the advances under its senior loan facility and holders of 100% of its outstanding 6.0% Senior Secured Convertible Notes due 2023 (the “Convertible Notes”). The parties to the RSA also hold in the aggregate approximately 67.4% of the outstanding equity interests of the Company (including outstanding warrants, but excluding outstanding the Convertible Notes) on a fully diluted basis. To implement the RSA and position SAE for future growth, the Company and certain of its subsidiaries have voluntarily filed...

Continue reading

Disclosure of received notification of NN Group NV

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 28 August 2020Disclosure of received notification of NN Group NVPursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received a notification of NN Group NV.Notification of NN Group NVOn 27 August 2020, Fagron received a notification that the shareholding of NN Group NV had crossed the disclosure threshold of 10% on 24 August 2020 as the result of the acquisition of voting securities or voting rights.The notification is made by a parent undertaking or a controlling person.On 24 August, NN Group NV (indirectly) held a total 7,248,055 voting rights. 5,203,216 voting rights are held by Nationale-Nederlanden Levensverzekering Maatschappij NV, 1,097,266 voting rights are held by NN Investment Partners BV, 597,862...

Continue reading

Openbaarmaking van ontvangen kennisgeving van NN Group NV

Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 28 augustus 2020Openbaarmaking van ontvangen kennisgeving van NN Group NVOvereenkomstig de Belgische Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in beursgenoteerde vennootschappen, heeft Fagron een kennisgeving van NN Group NV ontvangen.Kennisgeving van NN Group NVOp 27 augustus 2020 heeft Fagron een kennisgeving ontvangen dat het aandeelhouderschap van NN Group NV op 24 augustus de kennisgevingsdrempel van 10% heeft overschreden door de verwerving van stemrechtverlenende effecten of stemrechten.De kennisgeving vindt plaats door een moederonderneming of een controlerende persoon.Op 24 augustus bezit NN Group NV (indirect) in totaal 7.248.055 stemrechten. 5.203.216 stemrechten worden gehouden door Nationale-Nederlanden Levensverzekering Maatschappij...

Continue reading

Orphazyme announces Interim Report First Half 2020

Company announcementNo. 45/2020Orphazyme A/SOle Maaløes Vej 3DK-2200 Copenhagen NCVR No.: 32266355 Copenhagen, Denmark, August 28, 2020 – Orphazyme A/S (ORPHA.CO), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces its Interim Report First Half 2020 for the period January 1–June 30, 2020.Pipeline Highlights First Half 2020Reported positive data from 12-month open-label phase 2/3 extension clinical trial in Niemann-Pick disease Type C (NPC) showing sustained effect of arimoclomol in reducing disease progression over two yearsAnnounced a U.S. Early Access Program for NPCInitiated rolling submission of New Drug Application (NDA) for arimoclomol with the U.S. Food and Drug Administration (FDA) in NPC, which was subsequently completed in...

Continue reading

Ackermans & van Haaren: Half-year results 2020

Dear,Ackermans & van Haaren realised a net profit of 56.3 million euros in the first half of 2020 (H1 2019: 104.0 million euros, excluding 108.9 million euros capital gains).The results are expected to improve significantly in the second half of the year. The board of directors will propose to an extraordinary general meeting to pay a dividend of 2.32 euros per share in the fourth quarter of 2020.You can watch the video message of Jan Suykens, CEO of Ackermans & van Haaren, about the half-year results on our website or read our press release via the link below.Best regardsAckermans & van HaarenAttachmentAvH press release

Continue reading

Ackermans & van Haaren: Halfjaarresultaten 2020

Beste,Ackermans & van Haaren realiseert een nettowinst van 56,3 miljoen euro over het eerste halfjaar van 2020 (H1 2019: 104,0 miljoen euro, exclusief 108,9 miljoen euro meerwaarden).In de tweede jaarhelft wordt een duidelijke verbetering van de resultaten verwacht. De raad van bestuur zal aan een bijzondere algemene vergadering voorstellen om over te gaan tot de uitkering van een dividend van 2,32 euro per aandeel in Q4 2020.U kan de videoboodschap van Jan Suykens, CEO van Ackermans & van Haaren, over de halfjaarresultaten bekijken op onze website of ons persbericht lezen via de link onderaan.Met vriendelijke groetenAckermans & van HaarenBijlageAvH persbericht

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.